Background and Purpose— In a previous study, 0.3 and 0.45 mg/kg of intravenous recombinant
tissue plasminogen activator (rt-PA) were safe when combined with eptifibatide 75 mcg/…

Background Gender differences in the use of recombinant tissue-type plasminogen activator
(r-tPA) in stroke are complicated. In this study, we investigated gender differences using r-…

Background: The objective of this study was to characterize the comorbidities in a population
of patients with an acute ischaemic stroke, comparing patients that received recombinant …

Many advances in prevention, diagnosis, and treatment of neurologic disease have emerged
in the last few decades, resulting in reduced mortality and decreased disability. However, …

Spinal cord infarction is uncommon and usually presents with sudden onset of paralysis
and sensory disturbances. A variety of causes are described, but rarely with multiple factors …

Academic neurology departments must confront the challenges of developing a diverse
workforce, reducing inequity and discrimination within academia, and providing neurologic care …

Cluster headaches can be mimicked by a spontaneous carotid artery dissection. We report
a 45‐year‐old man with a spontaneous carotid artery dissection whose unilateral headache …

Both hereditary and acquired factors increase the risk of venous thromboembolism, thus the
clinical management of affected patients involves evaluation of genetic factors that …

Introduction: Train-of-four peripheral nerve stimulation assessment (TOF) has been shown
to lead to lower administered doses of neuromuscular blockers and faster recovery of …

Introduction: While train-of-four (TOF) assessment using peripheral nerve stimulation (PNS)
has become standard of practice for patients receiving continuous neuromuscular blockade, …